WELORNI contains L-Ornithine-L-Aspartate 250 mg + B-Complex + Niacinamide + Silymarin, formulated to provide hepatobiliary nutritional and antioxidant support. A differentiated PCD Pharma Hepatic Care portfolio offering.
Hepatic nutritional and supportive care as prescribed.
No; it is supportive therapy.
Use according to medical advice and alongside appropriate management of the underlying liver condition. Inform the physician about severe hepatic or renal impairment and other supplements/medicines.
Nausea, abdominal discomfort, diarrhea, headache or hypersensitivity may occur.
WELORNI: L-Ornithine-L-Aspartate supports ammonia detoxification through the urea cycle and glutamine synthesis, while Silymarin provides antioxidant support; B-complex vitamins and Niacinamide support nutritional metabolism.